Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study
-
Published:2023-11
Issue:
Volume:65
Page:102290
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Bai XueORCID, Shaheen Ahmed, Grieco Charlotte, d’Arienzo Paolo D., Mina Florentia, Czapla Juliane A., Lawless Aleigha R., Bongiovanni Eleonora, Santaniello Umberto, Zappi Helena, Dulak Dominika, Williamson Andrew, Lee Rebecca, Gupta Avinash, Li Caili, Si Lu, Ubaldi Martina, Yamazaki Naoya, Ogata DaiORCID, Johnson Rebecca, Park Benjamin C., Jung Seungyeon, Madonna Gabriele, Hochherz Juliane, Umeda Yoshiyasu, Nakamura YasuhiroORCID, Gebhardt Christoffer, Festino Lucia, Capone Mariaelena, Ascierto Paolo AntonioORCID, Johnson Douglas B., Lo Serigne N.ORCID, Long Georgina V.ORCID, Menzies Alexander M., Namikawa KenjiroORCID, Mandala Mario, Guo Jun, Lorigan Paul, Najjar Yana G., Haydon Andrew, Quaglino Pietro, Boland Genevieve M., Sullivan Ryan J., Furness Andrew J.S., Plummer Ruth, Flaherty Keith T.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|